← All organizations
Highest phase reached
Phase 2
First clinical trial
Aug 1, 2012Last known activity
Feb 15, 2018
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT04586608Reponsible party - principal investigatorN/AFeb 15, 2018
- NCT04586608Lead sponsorN/AFeb 15, 2018
- NCT02289196Overall official - principal investigatorPhase 1Mar 1, 2014
- NCT01935154Overall official - principal investigatorPhase 2Aug 1, 2012
Details
- Last known activity
- Feb 15, 2018